Clinical Trials
215
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (131 trials with phase data)• Click on a phase to view related trials
EVOLVING AZIMUTH IN MUSA CONTEXT
- Conditions
- Heart FailureBlood PressureWeight ChangeTelemonitoring
- First Posted Date
- 2025-06-15
- Last Posted Date
- 2025-06-15
- Target Recruit Count
- 184
- Registration Number
- NCT07022067
- Locations
- 🇮🇹
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's Disease. Open-label, Single-center Randomized Study
- Conditions
- Peyronie DiseasePenile CurvaturePRP InjectionCord BloodRandomised Clinical TrialPenile Injection Therapy
- First Posted Date
- 2025-06-08
- Last Posted Date
- 2025-06-08
- Target Recruit Count
- 42
- Registration Number
- NCT07010900
- Locations
- 🇮🇹
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Natural History of Familial Cerebral Cavernous Malformations: the CCM_Italia Cohort Study
- Conditions
- CCMFamilial Cerebral Cavernous Malformation
- First Posted Date
- 2025-05-21
- Last Posted Date
- 2025-05-21
- Target Recruit Count
- 100
- Registration Number
- NCT06983132
- Locations
- 🇮🇹
Policlinico di Bari, Bari, Italy
🇮🇹Careggi Hospital, Firenze, Firenze, Italy
🇮🇹Istituto Giannina Gaslini, Genova, Genova, Italy
Association of TNFAIP3 With Immune-mediated TTP
- Conditions
- Thrombotic Thrombocytopenic Purpura, Acquired
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-15
- Target Recruit Count
- 400
- Registration Number
- NCT06928233
- Locations
- 🇮🇹
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
Dietary Intervention to Improve Fertility in Women With Endometriosis Undergoing IVF
- Conditions
- Endometriosis
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-27
- Target Recruit Count
- 438
- Registration Number
- NCT06885125
- Locations
- 🇮🇹
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
- Prev
- 1
- 2
- 3
- 4
- 5
- 38
- Next
News
FDA Grants IDE Approval for Newronika's Novel Adaptive Deep Brain Stimulation System for Parkinson's Disease
• Newronika has received FDA Investigational Device Exemption (IDE) approval to commence a pivotal trial evaluating their adaptive deep brain stimulation system for movement disorders, particularly Parkinson's disease. • The company's innovative AlphaDBS system utilizes real-time brain signal feedback to deliver personalized stimulation therapy, potentially offering improved outcomes over conventional DBS treatments. • The upcoming multinational pivotal trial will compare the adaptive system's performance against traditional DBS in advanced Parkinson's disease patients, marking a crucial step toward U.S. regulatory approval.